申请人:——
公开号:US20030004139A1
公开(公告)日:2003-01-02
This invention relates to novel sulfonyl pyridazinone compounds useful as aldose reductase inhibitors in the treatment or prevention of certain complications arising from diabetes mellitus, pharmaceutical compositions comprising the sulfonyl pyridazinone, pharmaceutical compositions comprising a combination of the sulfonyl pyridazinone together with a second pharmaceutical agent, therapeutic methods comprising the administration of the sulfonyl pyridazinone compounds, therapeutic methods comprising the administration of the sulfonyl pyridazinone compounds in combination with a second pharmaceutical agent and compounds useful as intermediates for preparing the sulfonyl pyridazinone compounds of this invention.
这项发明涉及一种新型的磺酰基吡啶并酮化合物,可用作醛糖还原酶抑制剂,用于治疗或预防由糖尿病引起的某些并发症,包括含有磺酰基吡啶并酮的药物组合物,含有磺酰基吡啶并酮与第二药物剂的药物组合物,包括给予磺酰基吡啶并酮化合物的治疗方法,以及包括给予磺酰基吡啶并酮化合物与第二药物剂的组合的治疗方法,以及用作制备本发明磺酰基吡啶并酮化合物的中间体的化合物。